Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Belén Rivera Bravo"'
Publikováno v:
Anales de Radiología, México, Vol 23, Iss 1 (2024)
Los patrones de imagen en el sitio de vacunación y el drenaje de los ganglios linfáticos nos proporcionan información útil sobre la respuesta inmunitaria por la reciente introducción de la vacuna frente a la enfermedad por coronavirus 2019 (COVI
Externí odkaz:
https://doaj.org/article/5fe8eaf917d24681aef97ffa1b4564d5
Autor:
Michel Herranz-Carnero, Christian Buelna-Cano, Enrique Vallejo, Miguel A. Avila-Rodriguez, Belén Rivera-Bravo, Nora E. Kerik-Rotenberg
Publikováno v:
Gaceta Médica de México. 155
Autor:
Isabel Carvajal-Juarez, Belén Rivera-Bravo, Juan Carlos Plata-Corona, Felix Damas-De Los Santos, Nilda Espinola-Zavaleta, Erick Alexanderson-Rosas
Publikováno v:
Journal of Nuclear Cardiology. 29:1826-1831
Aneurysmal coronary artery disease includes coronary artery aneurysms and ectasia; this condition has been associated with poor long-term outcomes. Few studies have explored myocardial blood flow 13N-ammonia PET/CT MPI added value. We present a 45-ye
Autor:
Gerardo J. Ramírez-Nava, Clara Santos-Cuevas, Guillermina Ferro-Flores, Belén Rivera-Bravo, Mónica Janet Mendoza-Figueroa, Blanca Ocampo-García, Miguel A. Avila-Rodriguez
Publikováno v:
Nuclear Medicine and Biology. :54-60
Background The prostate-specific membrane antigen (PSMA) and the gastrin-releasing peptide receptor (GRPR) are overexpressed in prostate cancer (PCa). In preclinical studies, the iPSMA-Lys3-Bombesin (iPSMA-BN) heterodimeric ligand has shown a suitabl
Publikováno v:
Clinical Nuclear Medicine. 47:e120-e122
18F-prostate-specific membrane antigen (PSMA) 1007 is one of the most promising radiotracers for PET imaging in prostate cancer, minimal urinary clearance, and higher spatial resolution, which are the most outstanding features. PSMA can also be label
Autor:
David R. Cardoza-Ochoa, Cesar Cristancho-Rojas, David J. Pérez, Paola Moreno-Izaguirre, Melissa Guzman, María C. Gutiérrez-Rivera, Aarón P. Gaxiola-Mascareño, Miguel A. Avila-Rodríguez, Belén Rivera-Bravo
Publikováno v:
Nuclear medicine communications. 43(3)
The aim of the study was to evaluate the 18F-PSMA-1007 PET/computed tomography (CT) semiautomatic volumetric parameters to assess the whole-body tumor burden and its correlation with prostate-specific antigen (PSA) and Gleason score in patients with
Autor:
Edith García Luna, Belén Rivera Bravo, Keren Contreras Contreras, César Nicolás Cristancho Rojas
Publikováno v:
Revista de la Facultad de Medicina. 63:33-35
63 year old female patient with a clinical picture of 3 months of evolution manifested by dry cough, with no history of smoking. An image study identified left lung injury which was performed biopsy. Key words: Solitary pulmonary nodule; lung cancer;
Autor:
Manola Cuellar-Herrera, Francisco Velasco, Belén Rivera-Bravo, Pablo Eduardo Saucedo-Alvarado, Ana Luisa Velasco, A. Avendaño-Estrada, Miguel A. Avila-Rodriguez, Rene Marquez-Franco
Publikováno v:
Stereotactic and Functional Neurosurgery. 97:232-240
Background: Positron emission tomography (PET) imaging in epilepsy is an in vivo technique that allows the localization of a possible seizure onset zone (SOZ) during the interictal period. Stereo-electro-encephalography (SEEG) is the gold standard to
Autor:
Sandra Graciela Rosales Uvera, Georgina Valdés Becerril, Belén Rivera Bravo, Adriana Cecilia Puente Barragán
Publikováno v:
Revista de Sanidad Militar. 73:313-319
Introduccion: La enfermedad arterial coronaria (EAC) es causa importante de muerte y discapacidad. La imagen de tomografia por emision de positrones (PET) es hoy el metodo mas util en el abordaje de la EAC. El puntaje de calcio coronario (SCC) se cor
Autor:
Miguel A. Avila-Rodriguez, Enrique Vallejo, Nora E. Kerik-Rotenberg, Belén Rivera-Bravo, Christian Buelna-Cano, Michel Herranz-Carnero
Publikováno v:
Gaceta Médica de México. 155
Positron-emission tomography (PET) is a medical diagnostic technique by means of which functional images are obtained by recording the spatio-temporal biodistribution of specific radiopharmaceuticals targeted at specific molecular objectives, which p